N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors
- 3 May 2004
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (9), 2073-2078
- https://doi.org/10.1016/j.bmcl.2004.02.049
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitorsBioorganic & Medicinal Chemistry Letters, 2004
- Perspectives on Factor Xa InhibitionCurrent Medicinal Chemistry, 2001
- Chapter 8. Anticoagulants: Inhibitors of thrombin and factor XaPublished by Elsevier BV ,2001
- Platelet Glycoprotein IIb-IIIa Antagonists as Prototypical Integrin Blockers: Novel Parenteral and Potential Oral Antithrombotic AgentsJournal of Medicinal Chemistry, 2000
- Chapter 9. Factor Xa inhibitors: Recent advances in anticoagulant agentsPublished by Elsevier BV ,2000
- Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 1Journal of Medicinal Chemistry, 1999
- Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 2Journal of Medicinal Chemistry, 1999
- New Platelet Fibrinogen Receptor Glycoprotein IIb-IIIa Antagonists: Orally Active Series of N-Alkylated Amidines with a 6,6-Bicyclic TemplateJournal of Medicinal Chemistry, 1998
- Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro- 6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor XaJournal of Medicinal Chemistry, 1998
- GPIIb/IIIa Integrin Antagonists with the New Conformational Restriction Unit, Trisubstituted β-Amino Acid Derivatives, and a Substituted Benzamidine StructureJournal of Medicinal Chemistry, 1998